News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

David Stenehjem

Articles by David Stenehjem

97 Treatment Discontinuation Among Patients With Stage IV HER2–Negative Breast Cancer

ByChia Jie Tan,Connor Willis,Trang Au,Matthew Schabath, PhD,Chenghui Li,Kristen Kelley,Xiaoqing Xu,Leah Park,Clara Lam,Sandhya Mehta,Jackie Kwong,Diana Brixner,David Stenehjem

April 17th 2025

Latest Updated Articles

Trending on CancerNetwork

FDA Approves Diagnostic Tool for Pembrolizumab Combo in Endometrial Cancer

Leveraging Multidisciplinary Collaboration to Enhance RPT Benefit in Cancer

Nivolumab/Ipilimumab Improves Real-World Melanoma Outcomes Vs Pembrolizumab

Novel Anti-CD5 Therapy Earns FDA RMAT Designation in T-Cell Lymphoma

Neoadjuvant Cemiplimab/SBRT Yields Improved DFS in Resectable HCC

© 2025 MJH Life Sciences^®

All rights reserved.